Modeyso (dordaviprone capsules) — Cigna

Initial criteria

• Patient has a histone 3 (H3) K27M mutation; AND
• Patient has recurrent or progressive disease; AND
• Patient has received at least one prior therapy (examples of prior therapy include radiation, temozolomide, procarbazine, lomustine, or vincristine)

Approval duration

1 year